Mechanisms underlying the adaptive pulp and jaw bone trabecular changes in sickle cell anemia

Oral Dis. 2023 Mar;29(2):786-795. doi: 10.1111/odi.13998. Epub 2021 Aug 13.

Abstract

Objective: Mechanisms underlying the oral outcomes in sickle cell anemia (HbSS) have been less explored. This study aimed to investigate the association of morbimortality indicators and hydroxyurea use with adaptive pulp and jaw bone trabecular changes in HbSS.

Methods: This cross-sectional study included 123 individuals with HbSS. The exposures were the morbimortality indicators of HbSS (number of vaso-occlusive crises, organ damage, hemoglobin level, and leukocyte count) and the use of hydroxyurea for HbSS treatment. The outcomes were adaptive pulp and jaw bone trabecular changes confirmed by radiographic examination. Associations were estimated by Poisson regression in crude and adjusted analyses for sex, skin color, socioeconomic class, and age.

Results: The vaso-occlusive crises (mean ratio (MR) = 3.5, p = 0.045), lower hemoglobin (MR = 2.4, p = 0.037), and higher leukocyte count (MR = 2.17, p = 0.036) were risk factors, while the use of hydroxyurea was inversely associated with adaptive pulp changes (MR = 0.23, p = 0.024). The vaso-occlusive crises were associated with jaw bone trabecular changes (MR = 1.33, p = 0.02).

Conclusion: Adaptive pulp changes may be a potential clinical marker of chronic vasculopathy in HbSS. The use of hydroxyurea may reduce the frequency of adaptive pulp changes.

Keywords: bone changes; dental pulp; morbidity; mortality; sickle cell anemia.

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Cross-Sectional Studies
  • Dental Pulp Diseases* / diagnostic imaging
  • Dental Pulp Diseases* / etiology
  • Dental Pulp Diseases* / physiopathology
  • Hemoglobins
  • Humans
  • Hydroxyurea* / therapeutic use
  • Jaw Diseases* / diagnostic imaging
  • Jaw Diseases* / etiology
  • Risk Factors

Substances

  • Hemoglobins
  • Hydroxyurea